Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

3D Holographic Guidance, Navigation, and Control for Endovascular Aortic Repair

NCT: NCT06008613 · COMPLETED

NCT IDNCT06008613
StatusCOMPLETED
Start Date2023-10-18
Completion2025-06-19

Brief Summary

This is an Early Feasibility Study to evaluate the usability, safety and functionality of 3D holographic guidance, navigation, and control (3D-GNC) as an adjunct to and confirmed by fluoroscopic imaging to be used with Cook Zenith Flex AAA Endovascular Graft®.

Frequently Asked Questions

What is 3D Holographic Guidance, Navigation, and Control for Endovascular Aortic Repair?

3D Holographic Guidance, Navigation, and Control for Endovascular Aortic Repair is a clinical trial registered under NCT06008613. Current status: COMPLETED.

What is the status of NCT06008613?

The current status of NCT06008613 (3D Holographic Guidance, Navigation, and Control for Endovascular Aortic Repair) is: COMPLETED.

When did 3D Holographic Guidance, Navigation, and Control for Endovascular Aortic Repair start?

3D Holographic Guidance, Navigation, and Control for Endovascular Aortic Repair started on 2023-10-18.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑